Krystal Biotech (KRYS) Change in Inventory (2023 - 2026)
Krystal Biotech recorded quarterly Change in Inventory of $243000.0 in Q1 2026, down 77.03% quarter-over-quarter from $1.1 million in Q4 2025, and down 82.58% year-over-year from $1.4 million in Q1 2025.
Krystal Biotech's Change in Inventory history runs 4 years deep, the most recent figure standing at $243000.0 for Q1 2026.
- In Q1 2026, Change in Inventory fell 82.58% year-over-year to $243000.0; the TTM figure through Mar 2026 stood at $5.1 million (down 53.6% YoY), while the FY2025 annual figure was $6.3 million, down 47.21% from the prior year.
- Change in Inventory came in at $243000.0 for Q1 2026 at Krystal Biotech, down from $1.1 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $6.5 million in Q4 2024 to a low of -$880000.0 in Q2 2025.
- A 4-year average of $1.9 million and a median of $1.2 million in 2025 frame the typical range for Change in Inventory.
- On a YoY basis, Change in Inventory climbed as much as 1225.41% in 2024 and fell as far as 158.5% in 2024.
- Krystal Biotech's Change in Inventory stood at $492000.0 in 2023, then soared by 1225.41% to $6.5 million in 2024, then tumbled by 83.78% to $1.1 million in 2025, then plunged by 77.03% to $243000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $243000.0, $1.1 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243,000.00 |
| Mar 31, 2026 | 243,000.00 |
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 4.71 Mn |
| Sep 30, 2025 | 4.71 Mn |
| Jun 30, 2025 | -880,000.00 |
| Jun 30, 2025 | -880,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 6.52 Mn |
| Dec 31, 2024 | 6.52 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | -530,000.00 |
| Jun 30, 2024 | -530,000.00 |
| Mar 31, 2024 | 2.24 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | 492,000.00 |
| Dec 31, 2023 | 492,000.00 |
| Sep 30, 2023 | 3.08 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | 906,000.00 |
| Jun 30, 2023 | 906,000.00 |